WA
SGNT

Whitebox Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Whitebox Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-78,572
Closed -$1.25M – 163
2015
Q4 		$1.25M Sell
78,572
-2,937
-4% -$46.2K 0.03% 145
2015
Q3 		$1.25M Sell
81,509
-510
-0.6% -$11K 0.06% 215
2015
Q2 		$1.99M Sell
82,019
-24,470
-23% -$586K 0.09% 203
2015
Q1 		$2.48M Buy
+106,489
New +$2.82M 0.1% 172

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Whitebox Advisors's SGNT Position: Q1 2016 in Review

Whitebox Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q1 2016, closing a stake of 78,572 shares — an estimated $1.25M sold.

Whitebox Advisors first reported a position in SGNT in Q1 2015 and held it in 4 quarters. The position peaked at $2.48M in Q1 2015. 136 funds tracked by Wall St. Rank hold SGNT as of Q1 2016.

  • Whitebox Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Whitebox Advisors sold 78,572 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q1 2016, an estimated $1.25M.
  • Whitebox Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 4 quarters.
  • Whitebox Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.48M in Q1 2015.
  • 136 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q1 2016.

Based on Whitebox Advisors's 13F filing for Q1 2016, filed 3 May 2016.